Biological Implications of Tetramic Acid
Biological Implications of Tetramic Acid
批准号:
7511621
负责人:
Kim Janda
金额:
$23.74万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-22 至 2011-04-30
关键词:
ABI2 geneAcademic Medical CentersAcidsAffectAntibioticsBacteriaBehaviorBehavior ControlBindingBiochemicalBiologicalBiological ProcessBioluminescenceCandida albicansCell CommunicationCell DensityCellsClinicalCollaborationsCommunitiesComplexCystic FibrosisDataEnvironmentEukaryotic CellEvaluationExperimental DesignsFeedbackFluorescence MicroscopyGene ExpressionGenerationsGenesGenetic TranscriptionHumanImmune systemInfectionInvestigationIronLeadLightLungMetalsMicrobial BiofilmsMitogen-Activated Protein KinasesMolecularMorphologyN-butyrylhomoserine lactoneNetherlandsOrganismPathogenesisPathogenicityPatientsPlayPopulationProcessProductionPseudomonas aeruginosaPublicationsPyrrolidinesReactive Oxygen SpeciesResearch ProposalsRoleSeriesSiderophoresSignal Transduction PathwaySignaling MoleculeStaphylococcus aureusStarvationTestingVirulence FactorsYeastsbasecombatdesignhomoserine lactonein vivointerestmembermicroorganismnew therapeutic targetnovelpathogenpreventpublic health relevancepyrrolidinequorum sensingresearch studyuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Pseudomonas aeruginosa is a common environmental microorganism that has acquired the ability to take advantage of weaknesses in the host immune system to become an opportunistic pathogen in humans. Most prominent is the role of P. aeruginosa in patients suffering from cystic fibrosis as lung defense functions are severely impaired. Over the last 10 years, significant progress has been made in elucidating the molecular mechanisms underlying P. aeruginosa pathogenicity, in which quorum sensing plays a significant role. Two different AHLs, N-(3-oxododecanoyl) homoserine lactone (3-oxo- C12-HSL), synthesized by LasI, and N-butyrylhomoserine lactone (C4-HSL), synthesized by RhlI, have been identified as the main quorum sensing signaling molecules in P. aeruginosa. [PARAGRAPH] Recently, our discovery of a new nonenzymatically-formed product from 3-oxo-C12-HSL, the novel tetramic acid product, 3-(1-hydroxydecylidene)-5-(2-hydroxyethyl)pyrrolidine- 2,4-dione (C12-TA), has generated interest in the microbiological community as evident by the increasing number of citations our PNAS publication has received. Conceivably, this tetramic acid has a plethora of biological functions: P. aeruginosa might use C12-TA as an interference strategy to preclude encroachment by competing bacteria. Additionally, due to the tight and highly specific binding of iron(III) to C12-TA, comparable to known bacterial siderophores, we have hypothesized that this interaction may serve as a previously unrecognized primordial mechanism for iron solubilization and may provide P. aeruginosa with a competitive advantage in complex bacterial communities. Alternatively it might serve as an iron sequestering agent, removing free iron from the environment, thus preventing competing bacteria from obtaining essential iron while also serving as a feedback loop for P. aeruginosa to express genes controlled by the iron starvation Fur/PvdS transcription regulators. Significantly, we have shown that C12-TA affects morphology a in Candida albicans. [PARAGRAPH] Taken in total, we will present a set of hypotheses with highly focused experiments elucidate the molecular features and biochemical functions of N-(3-oxododecanoyl) homoserine lactone-derived C12-TA. PUBLIC HEALTH RELEVANCE: Our recent discovery of a new nonenzymatically-formed product derived from the main Pseudomonas aeruginosa quorum sensing molecule and the subsequent identification of a number of biological activities unrelated to quorum sensing itself provides the basis for further biochemical studies of this molecule, namely C12-TA. It is conceivable that P. aeruginosa might use C12-TA as an interference strategy to preclude encroachment by competing bacteria as well utilization as an iron sequestration and uptake agent, which might be an important survival strategy. Ultimately, the data obtained from the proposed experiments will lead to a deeper understanding of the P. aeruginosa pathogenesis and may uncover new therapeutic targets for combating P. aeruginosa infections.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
An Enzyme-Based Antidote for Acute Nicotine Toxicity
-
批准号:10790758
-
项目类别:
-
资助金额:$27.15万
-
财政年份:2023
-
负责人:Kim Janda
-
依托单位:
Discovering modulators of exonucleases PLD3 and PLD4 for immunoregulation
-
批准号:10620110
-
项目类别:
-
资助金额:$22.19万
-
财政年份:2022
-
负责人:Kim Janda
-
依托单位:
Discovering modulators of exonucleases PLD3 and PLD4 for immunoregulation
-
批准号:10353980
-
项目类别:
-
资助金额:$26.63万
-
财政年份:2022
-
负责人:Kim Janda
-
依托单位:
High-Throughput Screen for the Oncoprotein MYC
-
批准号:10276232
-
项目类别:
-
资助金额:$43.29万
-
财政年份:2021
-
负责人:Kim Janda
-
依托单位:
High-Throughput Screen for the Oncoprotein MYC
-
批准号:10657663
-
项目类别:
-
资助金额:$40.58万
-
财政年份:2021
-
负责人:Kim Janda
-
依托单位:
High-Throughput Screen for the Oncoprotein MYC
-
批准号:10436377
-
项目类别:
-
资助金额:$40.04万
-
财政年份:2021
-
负责人:Kim Janda
-
依托单位:
Covalent Inhibition as a Method to Counteract Botulinum Intoxication
-
批准号:10177867
-
项目类别:
-
资助金额:$63.79万
-
财政年份:2020
-
负责人:Kim Janda
-
依托单位:
Covalent Inhibition as a Method to Counteract Botulinum Intoxication
-
批准号:10408004
-
项目类别:
-
资助金额:$63.46万
-
财政年份:2020
-
负责人:Kim Janda
-
依托单位:
Covalent Inhibition as a Method to Counteract Botulinum Intoxication
-
批准号:10034607
-
项目类别:
-
资助金额:$69.27万
-
财政年份:2020
-
负责人:Kim Janda
-
依托单位:
Covalent Inhibition as a Method to Counteract Botulinum Intoxication
-
批准号:10624958
-
项目类别:
-
资助金额:$63.34万
-
财政年份:2020
-
负责人:Kim Janda
-
依托单位:
"PRODUCTION AND DISTRIBUTION OF INVESTIGATIONAL GHRELIN VACCINES-- GHRELIN VACCINES AGAINST RAT HORMONE". TASK ORDER 5. 09/21/2019-12/31/2020.
-
批准号:10037792
-
项目类别:
-
资助金额:$11.62万
-
财政年份:2019
-
负责人:Kim Janda
-
依托单位:
Immunotherapy to Counteract Lethal Doses of Carfentanil
-
批准号:9563769
-
项目类别:
-
资助金额:$52.07万
-
财政年份:2019
-
负责人:Kim Janda
-
依托单位:
IGF::OT::IGF:The Scripps Research Institute. Task Order 3 (HHSN275201500006I/HHSN27500003)."Production and Distribution of Investigational Ghrelin Vaccines--Ghrelin Vaccine Against Rat Hormone. 09/21/
-
批准号:9581309
-
项目类别:
-
资助金额:$12.24万
-
财政年份:2017
-
负责人:Kim Janda
-
依托单位:
A Multidisciplinary Approach for the Treatment of Botulinum Intoxication
-
批准号:9313771
-
项目类别:
-
资助金额:$56.62万
-
财政年份:2016
-
负责人:Kim Janda
-
依托单位:
Enzympharmacotherapy for attenuating nicotine's psychoactive effects
-
批准号:9342807
-
项目类别:
-
资助金额:$24.06万
-
财政年份:2016
-
负责人:Kim Janda
-
依托单位:
IGF::OT::IGF:THE SCRIPPS RESEARCH INSTITUTE. TASK ORDER 2 (HHSN275201500006I/HHSN27500002)."PRODUCTION AND DISTRIBUTION OF INVESTIGATIONAL GHRELIN VACCINES--GHRELIN VACCINE AGAINST RAT HORMONE. 09/21/
-
批准号:9361316
-
项目类别:
-
资助金额:$9.4万
-
财政年份:2016
-
负责人:Kim Janda
-
依托单位:
A Multidisciplinary Approach for the Treatment of Botulinum Intoxication
-
批准号:9179027
-
项目类别:
-
资助金额:$62.82万
-
财政年份:2016
-
负责人:Kim Janda
-
依托单位:
IGF::OT::IGF:THE SCRIPPS RESEARCH INSTITUTE. TASK ORDER 2 (HHSN275201500006I/HHSN27500002)."PRODUCTION AND DISTRIBUTION OF INVESTIGATIONAL GHRELIN VACCINES--GHRELIN VACCINE AGAINST RAT HORMONE. 09/21/
-
批准号:9521688
-
项目类别:
-
资助金额:$2.43万
-
财政年份:2016
-
负责人:Kim Janda
-
依托单位:
Using Allosteric Inhibition as a Means to Ablate Botulinum Neurotoxin Protease
-
批准号:9197258
-
项目类别:
-
资助金额:$24.06万
-
财政年份:2015
-
负责人:Kim Janda
-
依托单位:
Approaches to Counteract the Harmful Effects of Synthetic Opioid Designer Drugs
-
批准号:8912027
-
项目类别:
-
资助金额:$28.43万
-
财政年份:2015
-
负责人:Kim Janda
-
依托单位:
海外基金